Injectable Drug Delivery Articles
-
3 Lesser Known Keys To Effective Biopharma Supplier Engagement
6/4/2025
In this article, Fran DeGrazio lays out ways for biopharma companies developing and commercializing combination products and other drug delivery devices to ensure that their product requirements and related documentation needs are well met by suppliers of materials, devices, components, and services.
-
Connected Drug Delivery Devices: Emerging Market Trends
5/29/2025
Connected drug delivery devices integrate digital connectivity — often via Bluetooth — with traditional drug administration tools. New market research shares emerging growth and trends.
-
Tips From A Biomedical Engineer For Medical Device Innovation And Compliance
5/20/2025
Every new medical device feature must live within a quality management system that tracks design control, risk management, and post-market performance. Waiting until design freeze to loop in your quality and regulatory experts invites costly rework and setbacks.
-
Formulation Is Key For Y-mAbs' Self-Assembling Antibody
5/16/2025
The radiotherapy company's novel SADA construct uses self-assembling tetramers to deliver isotopes directly to cancer cells for a highly targeted, less toxic treatment.
-
The Future Of Biologics Delivery: High-Concentration Subcutaneous Injectables
5/12/2025
Once dominated by IV infusions administered in hospital settings, the biologics industry is now at a crossroads. Here's why the future of biologics delivery is high-concentration subcutaneous injectables.
-
Design Controls For Drug Delivery Devices, Part 2: A Practical Perspective
5/1/2025
In this article, Fran DeGrazio provides recommendations for implementing Design Controls in the development of combination products and other drug delivery devices. In outlining tips for drug-device product developers, Fran focuses on key considerations including risk management, chemical and functional compatibility, and regulatory compliance.
-
Smart Drug Delivery Systems: Emerging Market Trends
4/25/2025
According to new market research, the global smart drug delivery systems market reached $12 billion in 2024 and is expected to grow at a CAGR of 17% from 2025 to 2034. Check out this article for product trends and more.
-
Design Controls For Drug Delivery Devices, Part 1: A Process Primer
4/1/2025
In this article, Fran DeGrazio underscores the importance of design controls in the development of combination products and other drug delivery devices. She explains foundational concepts and fundamental steps including design inputs and outputs, design verification and validation, design review, and change controls.
-
The Importance Of Primary And Secondary Drying And Their Impact On Lyophilization
3/25/2025
For parenteral formulations, biologics, and vaccines, the lyophilization process's primary and secondary drying stages require precise control of temperature, vacuum, and duration.
-
The Technologies Propelling GLP-1 Analogues
3/18/2025
This article delves into the manufacturing and synthesizing technologies used to manufacture GLP-1 drugs as well as the novel drug delivery technologies being used.